Applied DNA Sciences (NASDAQ: APDN) reported Q1 EPS of ($0.63), $0.36 worse than the analyst estimate of ($0.27). Revenue for the quarter came in at $4.2 million versus the consensus estimate of $4.02 million.

For earnings history and earnings-related data on Applied DNA Sciences (APDN) click here.